Evidence map›Paper›PMID 40979995›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2025

May Measurement Month 2022: an analysis of blood pressure screening results from Colombia.

Jose P Lopez-Lopez, Johanna Otero, Zulma Urbina, Gregorio Sanchez-Vallejo, Claudia Narvaez, Paul A Camacho, Miguel Urina-Triana, Adalberto Quintero, Gustavo Aroca, Alfonso Campo and 8 more

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jose P Lopez-LopezMasira Research Institute, Universidad de Santander (UDES), Cl. 70 #N° 55-210, 680006 Bucaramanga, Colombia.ORCID https://orcid.org/0000-0001-8865-0929
Johanna OteroMasira Research Institute, Universidad de Santander (UDES), Cl. 70 #N° 55-210, 680006 Bucaramanga, Colombia.
Zulma UrbinaFacultad de Medicina, UDES, Cucuta, Colombia.
Gregorio Sanchez-VallejoHospital San Juan de Dios Armenia, Universidad del Quindio, Armenia, Colombia.
Claudia NarvaezDirección territorial de Salud de Caldas, Observatorio de Salud de Caldas, Manizales, Colombia.
Paul A CamachoDireccion de Investigaciones, FOSCAL, Floridablanca, Colombia.
Miguel Urina-TrianaFacultad de Medicina, Universidad Simon Bolivar and Fundacion BIOS, Barranquilla, Colombia.
Adalberto QuinteroFacultad de Medicina, Universidad Simon Bolivar and Fundacion BIOS, Barranquilla, Colombia.
Gustavo ArocaFacultad de Medicina, Universidad Simon Bolivar and Clınica de la Costa, Barranquilla, Colombia.
Alfonso CampoFacultad de Medicina, UDES, Cra 6 # 14-27, Valledupar, Cesar, Colombia.
Edgar ArcosDepartamento Endocrinología, Fundacion Centro de Obesidad y Metabolismo COMETA, Pasto, Nariño, Colombia.
Maritza Perez-MayorgaFacultad de Medicina, Universidad Militar Nueva Granada and Clínica Marly, Bogotá, Colombia.ORCID https://orcid.org/0000-0002-4240-6776
Walter MosqueraDepartamento de Cardiología Pediátrica, Fundacion Valle del Lili, Av. Simón Bolívar, Cra 98 # 18-49, Cali, Colombia.
Luis GarciaUnidad de Geriatría, Fundacion Centro De investigaciones Clinicas IPS Cardiomet, Pereira, Colombia.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.ORCID https://orcid.org/0000-0001-9709-7264
Gabriele KerrImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Patricio Lopez-JaramilloMasira Research Institute, Universidad de Santander (UDES), Cl. 70 #N° 55-210, 680006 Bucaramanga, Colombia.ORCID https://orcid.org/0000-0002-9122-8742

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The May Measurement Month (MMM) campaign was carried out in Colombia in 2022 with the aim of raising awareness of raised blood pressure (BP). Here, we report on the findings of the campaign. Adults aged ≥18 years were recruited opportunistically at healthcare and public facilities in 11 departments. Three seated BP readings were taken for each participant, along with completion of a questionnaire on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or being on antihypertensive medication. Controlled BP was defined as being on antihypertensive medication with a BP < 140/90 mmHg. Multiple imputation was used to estimate any missing BP readings. In total, 38 924 were screened, with a mean age of 46.3 years and 52.9% of whom were female. Of all participants, 10 738 (27.6%) had hypertension, of whom 7058 (65.7%) were aware, and 6925 (64.5%) were on antihypertensive medication. Of those on antihypertensive medication, 4600 (66.4%) had controlled BP, and of all participants with hypertension, 42.8% had controlled BP. However, those under 50 years had lower hypertension control (<30%). Women had a higher BP control than men (49.5% vs. 36.3%). High education was associated with lower systolic BP (-2.37 mmHg). The MMM campaign in Colombia identified significant numbers of participants with either untreated or inadequately treated hypertension. MMM22 results point to the need to continue improving awareness and seek a broader implementation of strategies with proven efficacy in controlling hypertension.

Indexed as

Blood pressureControlHypertensionScreening. Treatment

Identifiers

PMID40979995
PMCPMC12449205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.